Ticker Scorecard - BDTX Basics Company: Black Diamond Therapeutics, Inc. IPO Date: January 31, 2020 Sector: Healthcare Industry: Biotech Market Cap: $123.92M Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 3.67% Avg Daily Range (30 D): $0.07 | 3.14% Avg Daily Range (90 D): $0.13 | 3.61% Institutional Daily Volume Avg Daily Volume: .53M Avg Daily Volume (30 D): .86M Avg Daily Volume (90 D): 1M Trade Size Avg Trade Size (Sh.): 124 Avg Trade Size (Sh.) (30 D): 173 Avg Trade Size (Sh.) (90 D): 128 Institutional Trades Total Inst.Trades: 366 Avg Inst. Trade: $1.82M Avg Inst. Trade (30 D): $.61M Avg Inst. Trade (90 D): $1.74M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.25M Avg Closing Trade (30 D): $3.16M Avg Closing Trade (90 D): $2.8M Avg Closing Volume: 151.89K     News Nov 5, 2024 @ 1:00 PM Black Diamond Therapeutics Reports Third Quarter 2... Source: N/A Oct 7, 2024 @ 8:01 PM Black Diamond Therapeutics Announces Restructuring... Source: N/A Sep 22, 2024 @ 2:00 PM Black Diamond Therapeutics to Host Webcast Present... Source: N/A Sep 14, 2024 @ 7:30 AM Black Diamond Therapeutics Presents Real-World Tre... Source: N/A Jun 1, 2024 @ 2:00 PM Black Diamond Therapeutics Presents Promising BDTX... Source: Black Diamond Therapeutics, Inc Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.33 $-.28 $-.36 Diluted EPS $-1.33 $-.28 $-.36 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -73.1M $ -15.56M $ -19.91M Operating Income / Loss $ -81.36M $ -18.13M $ -22.13M Cost of Revenue $ $ $ Net Cash Flow $ -34.55M $ -9.38M $ 7.39M PE Ratio